BioWorld

Sep. 2, 2003

Explosions Hit Chiron In Wake Of Recent Animal Rights Protests

Chiron Corp. was bombed last week in what may have been the latest and most violent offense in a string of harassment incidents brought by animal rights protesters. (BioWorld Today) Read More

Target Discovery Totals $7M In Series A, Prepares For Market

Bayhill's Founders Model Innate, Adaptive Immunities To Dissect Autoimmune Diseases Like MS

Government Considers Changes To Medicare Reimbursement

Holiday notice

BioWorld's offices were closed Monday, Sept. 1, in observance of the Labor Day holiday in the U.S. No issue was published that day. Read More

Other News To Note

Correction

Today's news in brief

BioWorld

BioWorld briefs for June 10, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for June 10, 2025.

Corestemchemon preps US BLA filing for stem cell ALS therapy

BioWorld

Corestemchemon Inc. is planning to file a BLA for Neuronata-R (lenzumestrocel) by the end of 2025 to gain accelerated approval from the U.S. FDA, company...

Red blood cells in an artery with cholesterol

In two phase IIIs, Merck’s PCSK9 inhibitor cuts cholesterol

BioWorld

In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant...

Merck wins approval FDA in pediatric RSV and steps into CDC uncertainty

BioWorld

With the U.S. FDA’s approval of Enflonsia (cesrovimab) to prevent respiratory syncytial virus (RSV) infection lower respiratory tract disease in newborns and...